We are happy to announce that the 17th Annual Hepatitis B/C Conference will be taking place in-person on Saturday, November 11, 2023 from 8:00 AM to 5:00 PM EST at our updated venue: The NonProfit Center, 89 South Street, Suite 302, Boston, MA 02111-2680!
We are also ecstatic to announce that the Boston University Chobanian & Avedisian School of Medicine APAMSA Chapter will be collaborating to host this conference! APAMSA members and non-members are all welcome to register and attend.
WELCOME TO THE 17TH ANNUAL APAMSA HEPATITIS CONFERENCE!
Each year, we strive to collectively engage in the global fight against liver diseases, including hepatitis B and C, and to raise awareness about health disparities and their impact within the Asian American, Native Hawaiian, and Pacific Islander (AANHPI) population. We are excited to welcome you all in person in Boston, MA on 11/11/2023! Our members at Boston University have graciously partnered with us to put together the best conference yet!
The objectives of the conference are to raise awareness about the impact of liver diseases on the AANHPI community, to encourage future health care providers to advocate for policy changes to address the current health disparities that the AANHPI community face, to provide opportunities for current health profession students to network with prominent leaders in hepatology and to provide a venue for students to present their research on topics related to GI/hepatology.
Venue: The NonProfit Center
89 South Street, Suite 302
Boston, MA 02111-2680
SCHEDULE
8:00 AM – 8:50 AM: Registration/Breakfast
9:00 AM – 9:10 AM: Opening Remarks
9:20 AM – 10:05 AM: Dr. Su Wang
10:15 AM – 11:00 AM: Dr. Ponni Perumalswami
11:10 AM – 11:55 AM: Keynote Address by Dr. Anna Lok
12:00 PM – 1:45 PM: Lunch,
Research Poster Session & Oral Presentations
2:00 PM – 2:45 PM: Dr. Jason Blackard
3:00 PM – 3:50 PM: Breakout Sessions
4:00 PM – 4:30 PM Closing Remarks
9:00 PM – 12:00 AM Social (TBA)
Su Wang, MD, MPH, FACPMedical Director of Viral Hepatitis Programs and the Center for Asian Health at the Cooperman Barnabas Medical Center
Su Wang, MD, MPH, FACP is the Medical Director of Viral Hepatitis Programs and the Center for Asian Health at the Cooperman Barnabas Medical Center, part of the RWJBarnabas Health System in New Jersey.
Dr. Wang is a practicing internist and has served as principal investigator for a number of viral hepatitis screening and linkage-to-care grants sponsored by the US CDC and other funders. She has led primary care-based hepatitis B and C programs, community screening and outreach efforts, patient and community-based advocacy, and community based research initiatives.
She serves as Senior Advisor for Global Health for the Hepatitis B Foundation. She was also Past President of the World Hepatitis Alliance She has served on a number of WHO guideline development committees.
She received her Medical Degree from the University of Miami and her Masters of Public Health from Johns Hopkins School of Public Health. Dr. Wang completed a combined Internal Medicine and Pediatric residency at Georgetown University Hospital and then served as an Epidemic Intelligence Service officer for the Centers for Disease Control and Prevention (CDC) at the US Food and Drug Administration (FDA). She was previously the Director of Hepatitis Programs at the Charles B. Wang Community Health Center in New York City.
Ponni Perumalswami, MD, MSCRAssociate Professor of Gastroenterology & Hepatology
Dr. Perumalswami examines strategies to improve health services and access to care for patients with liver disease. She graduated from University of Michigan and received her M.S. in clinical research at Icahn School of Medicine at Mount Sinai. Dr. Perumalswami received her M.D. degree from Wayne State University. Her research focuses on the development of clinical and behavioral health care models to identify and address system-level barriers to liver care within underserved and vulnerable communities. In 2020, Perumalswami joined the steering committee of the Michigan Department of Health and Human Services’ Hepatitis C Virus Elimination Plan, which informs policy and practice to mitigate the spread of viral hepatitis. She also works with the Michigan Opioid Collaborative on outreach and training initiatives aimed at increasing hepatitis C screening and treatment by primary care providers in rural areas of the state.
Anna Suk-Fong Lok, MD Assistant Dean for Clinical ResearchDame Sheila Sherlock Distinguished University Professor of Hepatology and Internal Medicine
Dr. Anna Lok graduated from University of Hong Kong Medical School. She completed her medicine training at Queen Mary Hospital, Hong Kong and hepatology training in London. She was a faculty at the University of Hong Kong until she moved to the US in 1992. She joined the University of Michigan in 1995 as Director of the Hepatology Program. She became Associate Chair for Clinical Research in the Department of Internal Medicine in 2008 and Assistant Dean for Clinical Research in 2016.
Dr. Lok’s research focuses on natural history and treatment of hepatitis B and C. She has published more than 600 papers on viral hepatitis and liver diseases, including five iterations of the American Association for the Study of Liver Diseases (AASLD) guidelines on “Hepatitis B”. She also participated in the development of the first World Health Organization (WHO) guidelines on hepatitis B and C. She was one of the top 1% most cited researchers in the world for the period 2002-2012. Dr. Lok served as Associate Editor of Hepatology in 2002-2006, Senior Associate Editor of Gastroenterology in 2011-2012, and President of AASLD in 2017. She has mentored many fellows and faculty and was recognized with an American Gastroenterological Association Distinguished Mentor Award. She was elected to the National Academy of Medicine in 2022
Jason T. Blackard, PhDProfessor, University of Cincinnati
Dr. Blackard received his PhD in Biological Sciences in Public Health at Harvard University in Boston, MA (2000). He completed a post-doctoral fellowship (2002-2005) at Massachusetts General Hospital where he investigated the interactions of flaviviruses with the human immunodeficiency virus.
Dr. Blackard directs a translational research laboratory focusing on human and mechanistic studies to understand virus-virus and virus-host interactions. Current work involves studies of hepatitis B (HBV), hepatitis C (HCV), human pegivirus (HPgV), HIV, and BK polyomavirus.
******Research Submission Information*******
DEADLINE EXTENDED
DEADLINE: 10/23/2023 at 11:59 PM CST
Thank you for your interest in submitting your research for consideration for presentation at the 17th Annual APAMSA Hepatitis Conference. We look forward to evaluating your hard work. We prefer research to cover GI/Hepatology topics but also accept research related to AANHPI communities.
The poster session is tentatively scheduled for 12 PM to 2 PM. At least one author is required to give a presentation during this time. Poster awards will be given by our judges.
To submit your abstract, please submit it here by October 23rd at 11:59PM CST.
Please contact us at hepatitis@apamsa.org if you have any questions.
REGISTRATION:
To register, please fill out and pay through the registration form. Both steps must be completed in order for you to be fully registered. Below are our registration deadlines:
- Early Bird Registration: $30, Ends October 7th, 2023
- Regular Registration: $35, Ends October 29th, 2023
- Late Registration: $40, Ends November 4th, 2023
TRAVEL SUBSIDY:
To receive financial aid to attend the Hepatitis Conference, please fill out the travel subsidy application.
HOUSING INFORMATION:
Ming Lin
Health Affairs Vice President
Medical College of Wisconsin
Christopher Huy Doan
Hepatitis Director
John Sealy School of Medicine at UTMB Galveston
Jay Lee
Hepatitis Director
A.T. Still University School of Osteopathic Medicine in Arizona
Jane Park
Hepatitis Director
Western University of Health Sciences College of Osteopathic Medicine
Justin Yun
Hepatitis Speakers Committee
John Sealy School of Medicine at UTMB Galveston
Bunnarin Theng
Hepatitis Speakers Committee
John Sealy School of Medicine at UTMB Galveston
Jasmine Haraburda
Hepatitis Speakers Committee
University of Cincinnati College of Medicine
Jamyang Choedon
Hepatitis Logistics Committee
Touro College of Osteopathic Medicine – Harlem
Kevin Yu
Hepatitis Logistics Committee
NYIT College of Osteopathic Medicine
Robert Hu
Hepatitis Logistics Committee
Creighton University School of Medicine
Danny Domingo
Hepatitis Graphics Committee
Western University of Health Sciences College of Osteopathic Medicine
Peter Wang
Hepatitis Graphics Committee
John Sealy School of Medicine at UTMB Galveston
David Wang
Hepatitis Graphics Committee
John Sealy School of Medicine at UTMB Galveston
Contact Us
Questions? Email us at hepatitis@apamsa.org.
.